E11.9

Type 2 diabetes mellitus without complications

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from a combination of progressive insulin resistance and an inadequate compensatory insulin secretory response by pancreatic beta cells. While the specific code E11.9 denotes that no acute or chronic complications—such as nephropathy, retinopathy, neuropathy, or vascular disease—have been clinically identified at the time of assessment, the condition still requires rigorous management. The pathophysiology involves impaired glucose uptake in peripheral tissues (primarily skeletal muscle and adipose tissue) and increased hepatic glucose production. Over time, poorly managed T2DM can lead to significant organ damage, but patients classified under E11.9 are currently managed via lifestyle modifications, oral anti-diabetic agents, or insulin without evidence of current end-organ manifestations. Clinical monitoring focuses on HbA1c levels, lipid profiles, and early screening for the transition into complicated states.

Clinical Symptoms

  • Polyuria (excessive urination)
  • Polydipsia (excessive thirst)
  • Polyphagia (increased hunger)
  • Fatigue and lethargy
  • Blurred vision
  • Slow-healing sores or frequent infections
  • Unintended weight loss (less common than in Type 1)
  • Acanthosis nigricans (darkened skin patches indicating insulin resistance)
  • Numbness or tingling in hands or feet (pre-clinical neuropathy)
  • Irritability and mood changes

Common Causes

  • Genetic predisposition and family history
  • Overweight and obesity (especially visceral adiposity)
  • Insulin resistance in muscle, liver, and fat cells
  • Physical inactivity and sedentary lifestyle
  • Metabolic syndrome (hypertension, dyslipidemia)
  • Advanced age (risk increases significantly after age 45)
  • History of gestational diabetes
  • Polycystic ovary syndrome (PCOS)
  • Ethnicity (higher prevalence in African American, Hispanic, Native American, and Asian American populations)
  • Impaired glucose tolerance or impaired fasting glucose (prediabetes)

Documentation & Coding Tips

Explicitly state the type of diabetes as Type 2 to avoid defaulting to unspecified types, which can lead to clinical and billing ambiguity.

Example: 65-year-old male with Type 2 diabetes mellitus without complications, currently managed with diet and metformin. Hemoglobin A1c is stable at 6.8 percent. No signs of retinopathy, neuropathy, or nephropathy on current physical examination and recent screening tests. Patient remains asymptomatic with no polyuria or polydipsia.

Billing Focus: Specifying Type 2 and the absence of complications supports the selection of E11.9 over more complex codes, ensuring accuracy in the encounter record.

Clearly document the long-term use of insulin or non-insulin injectable medications using supplementary Z codes to provide a complete clinical picture.

Example: Diagnosis: Type 2 diabetes mellitus without complications. Medication management includes long-term use of insulin glargine (20 units nightly) and metformin. Foot exam is negative for ulcers or sensory loss. Renal function is within normal limits with a BMP showing creatinine of 0.9.

Billing Focus: Including Z79.4 (Long term use of insulin) alongside E11.9 identifies specific therapeutic requirements and complexity.

Differentiate between controlled and uncontrolled status even when no specific complications are present, as this impacts the medical decision making complexity.

Example: Patient presents with Type 2 diabetes mellitus without complications. Blood sugar logs show fasting levels between 140 and 160, indicating the condition is currently inadequately controlled. Plan involves increasing Metformin dosage and lifestyle counseling. No evidence of end-organ damage noted at this time.

Billing Focus: Documentation of glycemic control status supports the complexity of Medical Decision Making (MDM) for E/M coding (e.g., 99214).

Link the absence of complications to the results of recent screening procedures to validate the use of the E11.9 code.

Example: Annual wellness exam for patient with Type 2 diabetes mellitus without complications. Most recent monofilament test was normal (10/10 sites), and urine microalbumin/creatinine ratio was 15 mg/g. Dilated eye exam by ophthalmology last month showed no diabetic retinopathy. Assessment: Stable DM2 without complications.

Billing Focus: Documenting negative screening findings justifies the high specificity of the E11.9 diagnosis code.

Document associated comorbidities such as obesity or hypertension separately to capture the full patient risk profile without incorrectly implying a causal link to the diabetes.

Example: Assessment: Type 2 diabetes mellitus without complications. Comorbid conditions include essential hypertension and morbid obesity with a BMI of 42.5. Patient is here for follow-up of all three chronic conditions. Diabetes is managed with glipizide; hypertension is stable on lisinopril.

Billing Focus: Reporting E11.9 with I10 and E66.01 accurately reflects the patient's multifaceted health status without overcoding diabetic complications.

Relevant CPT Codes

Related Diagnoses

Hierarchy